Nypozi 480 mcg (Filgrastim SOLUTION) 480 MCG

NYPOZI 480 MCG is a solution containing filgrastim, used to stimulate the production of white blood cells. This intravenous medication supports the immune system, often during cancer treatments or bone marrow transplants.

Strength

480 MCG

Manufacturer / TM Owner

TANVEX BIOPHARMA USA, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NYPOZI 480 MCG is primarily used to boost white blood cell counts in individuals undergoing chemotherapy or bone marrow transplants. It helps reduce the risk of infections by supporting the immune system. This medication is also used in certain medical conditions where white blood cell production is low.

Side Effects

Common effects of NYPOZI 480 MCG may include mild bone or muscle aches, headaches, and fatigue. Some individuals might experience temporary swelling or redness at the injection site. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

NYPOZI 480 MCG should be handled with care, following the instructions provided by a healthcare professional. It is important to store the solution properly and use it as directed. Individuals with a history of allergic reactions to filgrastim or similar medications should consult their healthcare provider before use.

Avoid Interactions

NYPOZI 480 MCG may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

Frequently Asked Questions

NYPOZI 480 MCG is used to stimulate the production of white blood cells, often during chemotherapy or bone marrow transplants.

NYPOZI 480 MCG is administered intravenously, typically by a healthcare professional.

Common side effects may include bone or muscle aches, headaches, and fatigue.

It is important to consult a healthcare provider before combining NYPOZI 480 MCG with other medications to avoid potential interactions.

NYPOZI 480 MCG should be stored according to the instructions provided by the manufacturer to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.